{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T07:27:40Z","timestamp":1748244460883,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T00:00:00Z","timestamp":1567382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T00:00:00Z","timestamp":1567382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-4401-9","type":"journal-article","created":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T18:07:41Z","timestamp":1567447661000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Human immunodeficiency virus-associated tuberculosis care in Botswana: evidence from a real-world setting"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8476-5024","authenticated-orcid":false,"given":"Ley Muyaya","family":"Muyaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esperance Manwana","family":"Musanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques Lukenze","family":"Tamuzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,2]]},"reference":[{"key":"4401_CR1","unstructured":"UNAIDS. Fact sheet: Latest statistics on the status of the AIDS epidemic. http:\/\/www.unaids.org\/en\/resources\/fact-sheet . [Accessed 29 Jan 2019]."},{"key":"4401_CR2","unstructured":"World Health Organization. Global Tuberculosis report. Geneva; 2018. http:\/\/www.who.int\/tb\/publications\/global_report\/en\/ [Accessed 29 Jan 2019]"},{"key":"4401_CR3","unstructured":"World Health Organization. The end TB strategy. http:\/\/www.who.int\/tb\/strategy\/en\/ [Accessed 1 Nov 2017]."},{"key":"4401_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/00002030-200101260-00002","volume":"15","author":"YD Mukadi","year":"2001","unstructured":"Mukadi YD, Dermot M, Anthony H. Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS. 2001;15:143\u201352.","journal-title":"AIDS"},{"issue":"1","key":"4401_CR5","first-page":"27","volume":"66","author":"K Styblo","year":"1991","unstructured":"Styblo K. The impact of HIV infection on the global epidemiology of tuberculosis. Bull Int Union Tuberc Lung Dis. 1991;66(1):27\u201332.","journal-title":"Bull Int Union Tuberc Lung Dis"},{"key":"4401_CR6","volume-title":"Treatment of tuberculosis guidelines","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. Treatment of tuberculosis guidelines. 4th ed; 2010. http:\/\/www.who.int\/tb\/publications\/2010\/9789241547833\/en\/ [Accessed Mar 2015]","edition":"4"},{"issue":"3","key":"4401_CR7","first-page":"225","volume":"5","author":"M Badri","year":"2001","unstructured":"Badri M, Ehrlich R, Wood R, Pulerwitz T, Maartens G. Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area. Int J Tuberc Lung Dis. 2001;5(3):225\u201332.","journal-title":"Int J Tuberc Lung Dis"},{"key":"4401_CR8","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1097\/QAD.0000000000000802","volume":"29","author":"RK Gupta","year":"2015","unstructured":"Gupta RK, Lucas SB, Fielding KL, Lawn SD. Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis. AIDS. 2015;29:1987\u20132002.","journal-title":"AIDS"},{"issue":"4","key":"4401_CR9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ccm.2009.08.010","volume":"30","author":"SD Lawn","year":"2009","unstructured":"Lawn SD, Kranzer K, Wood R. Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings. Clin Chest Med. 2009;30(4):685\u201399.","journal-title":"Clin Chest Med"},{"issue":"9163","key":"4401_CR10","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/S0140-6736(99)03465-0","volume":"353","author":"SZ Wiktor","year":"1999","unstructured":"Wiktor SZ, Sassan-Morokro M, Grant AD, et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, cote d'Ivoire: a randomised controlled trial. Lancet. 1999;353(9163):1469\u201375.","journal-title":"Lancet"},{"key":"4401_CR11","doi-asserted-by":"publisher","first-page":"a257","DOI":"10.1136\/bmj.a257","volume":"337","author":"AJ Nunn","year":"2008","unstructured":"Nunn AJ, Mwaba P, Chintu C, et al. Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial. Bmj. 2008;337:a257.","journal-title":"Bmj"},{"key":"4401_CR12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.5588\/pha.14.0109","volume":"2","author":"H Kanyerere","year":"2015","unstructured":"Kanyerere H, Mganga A, Harries AD, et al. Decline in national tuberculosis notifications with national scale-up of antiretroviral therapy in Malawi. Public Health Action. 2015;2:116\u20138.","journal-title":"Public Health Action"},{"issue":"2","key":"4401_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.5588\/pha.15.0081","volume":"6","author":"G Mchunu","year":"2016","unstructured":"Mchunu G, Van Griensven J, Hinderaker SG, et al. High mortality in tuberculosis patients despite HIV interventions in Swaziland. Public Health Action. 2016;6(2):105\u201310.","journal-title":"Public Health Action"},{"key":"4401_CR14","volume-title":"Botswana National Tuberculosis Control Program, Annual report","author":"Ministry of Health","year":"2013","unstructured":"Ministry of Health. Botswana National Tuberculosis Control Program, Annual report; 2013."},{"key":"4401_CR15","volume-title":"Botswana National ARV Therapy Programme, National HIV & AIDS Treatment Guidelines","author":"Ministry of Health","year":"2012","unstructured":"Ministry of Health. Botswana National ARV Therapy Programme, National HIV & AIDS Treatment Guidelines; 2012."},{"key":"4401_CR16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/QAD.0b013e328013f632","volume":"21","author":"D Moore","year":"2007","unstructured":"Moore D, Liechty C, Ekwaru P, et al. Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. AIDS. 2007;21:713\u20139 PMID: 17413692.","journal-title":"AIDS"},{"key":"4401_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/QAI.0b013e3181f9fb39","volume":"56","author":"A Van Rie","year":"2011","unstructured":"Van Rie A, Westreich D, Sanne I. Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors and prevention strategies. J Acquir Immune Defic Syndr. 2011;56:349\u201355 PMID: 20926954.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4401_CR18","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1097\/QAD.0b013e32832d3b6d","volume":"23","author":"SD Lawn","year":"2009","unstructured":"Lawn SD, Myer L, Edwards D, Bekker LG, Wood R. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS. 2009;23:1717\u201325 PMID: 19461502.","journal-title":"AIDS"},{"key":"4401_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/QAI.0b013e318218a713","volume":"57","author":"S Nicholas","year":"2011","unstructured":"Nicholas S, Sabapathy K, Ferreyra C, Varaine F, Pujades-Rodriguez M. Incidence of tuberculosis in HIV-infected patients before and after starting combined antiretroviral therapy in 8 sub-Saharan African HIV programs. J Acquir Immune Defic Syndr. 2011;57:311\u20138 PMID: 21423023.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4401_CR20","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1164\/rccm.200709-1311PP","volume":"177","author":"SD Lawn","year":"2008","unstructured":"Lawn SD, Wilkinson RJ, Lipman MC, Wood R. Immune reconstitution and \u201cunmasking\u201d of tuberculosis during antiretroviral therapy. Am J Respir Crit Care Med. 2008;177:680\u20135 PMID: 18202347.","journal-title":"Am J Respir Crit Care Med"},{"key":"4401_CR21","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/QAD.0b013e3283390dd1","volume":"24","author":"SD Lawn","year":"2010","unstructured":"Lawn SD, Kranzer K, Edwards DJ, McNally M, Bekker LG, Wood R. Tuberculosis during the first year of antiretroviral therapy in a south African cohort using an intensive pretreatment screening strategy. AIDS. 2010;24:1323\u20138 PMID: 20386425.","journal-title":"AIDS"},{"key":"4401_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/QAD.0b013e32831d2a98","volume":"23","author":"SD Lawn","year":"2009","unstructured":"Lawn SD, Wainwright H, Orrell C. Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages. AIDS. 2009;23:143\u20135 PMID: 19050399.","journal-title":"AIDS"},{"key":"4401_CR23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1136\/sti.79.4.337","volume":"79","author":"NR Goldsack","year":"2003","unstructured":"Goldsack NR, Allen S, Lipman MC. Adult respiratory distress syndrome as a severe immune reconstitution disease following the commencement of highly active antiretroviral therapy. Sex Transm Infect. 2003;79:337\u20138 PMID: 12902592.","journal-title":"Sex Transm Infect"},{"key":"4401_CR24","doi-asserted-by":"publisher","first-page":"e1000391","DOI":"10.1371\/journal.pmed.1000391","volume":"8","author":"H Getahun","year":"2011","unstructured":"Getahun H, Kittikraisak W, Heilig CM, Corbett EL, Ayles H, Cain KP, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med. 2011;8:e1000391.","journal-title":"PLoS Med"},{"issue":"17","key":"4401_CR25","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1097\/QAD.0b013e3283565dd1","volume":"26","author":"Stephen D. Lawn","year":"2012","unstructured":"Lawn SD, Harries AD, Meintjes G, et al. Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2012;26(17).","journal-title":"AIDS"},{"key":"4401_CR26","unstructured":"The use of lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis and screening of active tuberculosis in people living with HIV Policy update https:\/\/www.who.int\/tb\/publications\/use-of-lf-lam-tb-hiv\/en\/ [Accessed Mar 2019]."},{"issue":"10144","key":"4401_CR27","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S0140-6736(18)31267-4","volume":"392","author":"A Gupta-Wright","year":"2018","unstructured":"Gupta-Wright A, Corbett EL, Van Oosterhout JJ, Fielding K, et al. Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial. Lancet. 2018;392(10144):292\u2013301.","journal-title":"Lancet"},{"key":"4401_CR28","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1097\/QAD.0b013e328216f441","volume":"21","author":"JE Golub","year":"2007","unstructured":"Golub JE, Saraceni V, Cavalcante SC, et al. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro. Brazil AIDS. 2007;21:1441\u20138 PMID: 17589190.","journal-title":"Brazil AIDS"},{"issue":"5","key":"4401_CR29","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/QAD.0b013e328327964f","volume":"23","author":"JE Golub","year":"2009","unstructured":"Golub JE, Pronyk P, Mohapi L, et al. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS. 2009;23(5):631\u20136.","journal-title":"AIDS"},{"key":"4401_CR30","doi-asserted-by":"publisher","first-page":"e45704","DOI":"10.1371\/journal.pone.0045704","volume":"7","author":"CA Schmaltz","year":"2012","unstructured":"Schmaltz CA, Santoro-Lopes G, Louren\u00e7o MC, Morgado MG, De Souza Velasque L, Rolla VC. Factors impacting early mortality in tuberculosis\/HIV patients: differences between subjects naive to and previously started on HAART. PLoS One. 2012;7:e45704.","journal-title":"PLoS One"},{"key":"4401_CR31","doi-asserted-by":"publisher","first-page":"e73250","DOI":"10.1371\/journal.pone.0073250","volume":"8","author":"I Ismail","year":"2013","unstructured":"Ismail I, Awang B. Predictors of death during tuberculosis treatment in TB\/HIV co-infected patients in Malaysia. PLoS One. 2013;8:e73250.","journal-title":"PLoS One"},{"key":"4401_CR32","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1056\/NEJMoa0905848","volume":"362","author":"SS Abdool Karim","year":"2010","unstructured":"Abdool Karim SS, Naidoo K, Grobler A, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med. 2010;362:697\u2013706.","journal-title":"N Engl J Med"},{"key":"4401_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.7326\/M14-2979","volume":"163","author":"OA Uthman","year":"2015","unstructured":"Uthman OA, Okwundu C, Gbenga K, et al. Optimal timing of antiretroviral therapy initiation for HIV-infected adults with newly diagnosed pulmonary tuberculosis: a systematic review and meta-analysis. Ann Intern Med. 2015;163:32\u20139.","journal-title":"Ann Intern Med"},{"key":"4401_CR34","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1056\/NEJMoa1014181","volume":"365","author":"SS Abdool Karim","year":"2011","unstructured":"Abdool Karim SS, Naidoo K, Grobler A, et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med. 2011;365:1492\u2013501.","journal-title":"N Engl J Med"},{"key":"4401_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/MD.0000000000010486","volume":"97","author":"LM Muyaya","year":"2018","unstructured":"Muyaya LM, Young T, Loveday M. Predictors of mortality in adults on treatment for human immunodeficiency virus-associated tuberculosis in Botswana: a retrospective cohort study. Medicine. 2018;97:16.","journal-title":"Medicine"},{"key":"4401_CR36","volume-title":"Botswana National ARV Therapy Programme, National HIV & AIDS Treatment Guidelines","author":"Ministry of Health","year":"2016","unstructured":"Ministry of Health. Botswana National ARV Therapy Programme, National HIV & AIDS Treatment Guidelines; 2016."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4401-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4401-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4401-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T05:23:21Z","timestamp":1664256201000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4401-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,2]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4401"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4401-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2019,9,2]]},"assertion":[{"value":"23 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Permission to conduct this study was obtained from Stellenbosch University (reference number S15\/05\/116), the Ministry of Health of Botswana (reference number PPME13\/18\/1 PS V (357)) and the local health authorities of the Serowe\/Palapye district. Routine data regularly collected by healthcare providers for clinical care were used in this study. Therefore, informed consent was waived by the ethics committees, as the study used data previously collected for clinical routine care.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"767"}}